Examined

Examined

Do Ozempic/Wegovy and the like increase risk of sudden vision loss?

Popular weight loss and diabetes medications called GLP-1 agonists and a recent JAMA study.

Ryan McCormick, M.D.'s avatar
Ryan McCormick, M.D.
Sep 05, 2024
∙ Paid

There is not a day I practice medicine anymore that I’m not fielding questions about GLP-1 medications like Ozempic and Wegovy, Mounjaro and Zepbound. Many people have had tremendous success controlling their type 2 diabetes and/or losing weight while consequently reducing the burden of their other comorbid conditions. Some have had side effects that …

Keep reading with a 7-day free trial

Subscribe to Examined to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2026 Ryan McCormick · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture